Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Psychoneuroendocrinology ; 158: 106382, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37708823

RESUMO

Many animals react to threatening stimuli such as a predator attacks by freezing. However, little experimental research investigated freeze response in humans. Here, we have employed practices commonly used in self-defense training to create two unique scenarios simulating armed physical threat. Sixty healthy men volunteers divided into three groups of twenty (untrained, trained but unexperienced, trained and experienced) underwent these scenarios accompanied by measurement of biochemical, physiological, and psychological markers of stress. Our results show that untrained individuals exhibit stronger freezing reactions, while highly skilled participants display the lowest propensity for freezing, especially in high-intensity scenarios. Moreover, the study shows variations in anxiety levels and selected biomarkers, with cortisol and osteocalcin showing different patterns in low and high-intensity scenarios, and suggests a complex interplay between these factors, electrodermal activity, and stress perception.


Assuntos
Fatores Biológicos , Autoimagem , Masculino , Animais , Humanos , Hidrocortisona , Estresse Psicológico/psicologia
2.
Anticancer Res ; 37(5): 2275-2288, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28476793

RESUMO

BACKGROUND/AIM: Expression profiling was performed to delineate and characterize the impact of malignancy by comparing tissues from three sites of head and neck cancer of each patient, also determining interindividual variability. MATERIALS AND METHODS: Genome-wide analysis was carried out covering the expression of 25,832 genes with quantification for each site of seven patients with tonsillar or oropharyngeal squamous cell carcinoma. Immunohistochemical analysis was performed for adhesion/growth-regulatory galectins, three pro-inflammatory chemo- and cytokines and keratins. RESULTS: Up- and down-regulation was found for 281 (tumor vs. normal) and 276 genes (transition zone vs. normal), respectively. The profile of the transition zone had its own features, with similarity to the tumor. Galectins were affected in a network manner, with differential regulation and interindividual variability between patients, also true for keratins and the chemo- and cytokines. CONCLUSION: These results underline special features at each site of specimen origin as well as the importance of analyzing galectins as a network and of defining the expression status of the individual patient prior to reaching clinically relevant conclusions.


Assuntos
Carcinoma de Células Escamosas/genética , Galectinas/genética , Neoplasias Orofaríngeas/genética , Idoso , Carcinoma de Células Escamosas/metabolismo , Citocinas/genética , Epitélio/metabolismo , Feminino , Galectinas/metabolismo , Perfilação da Expressão Gênica , Genoma Humano , Humanos , Queratinas/genética , Queratinas/metabolismo , Masculino , Pessoa de Meia-Idade , Neoplasias Orofaríngeas/metabolismo
3.
Oncotarget ; 8(65): 109319-109331, 2017 12 12.
Artigo em Inglês | MEDLINE | ID: mdl-29312610

RESUMO

Many tyrosine kinase inhibitors (TKIs) have failed to reach human use due to insufficient activity in clinical trials. However, the failed TKIs may still benefit patients if their other kinase targets are identified by providing treatment focused on syndromes driven by these kinases. Here, we searched for novel targets of AZD1480, an inhibitor of JAK2 kinase that recently failed phase two cancer clinical trials due to a lack of activity. Twenty seven human receptor tyrosine kinases (RTKs) and 153 of their disease-associated mutants were in-cell profiled for activity in the presence of AZD1480 using a newly developed RTK plasmid library. We demonstrate that AZD1480 inhibits ALK, LTK, FGFR1-3, RET and TRKA-C kinases and uncover a physical basis of this specificity. The RTK activity profiling described here facilitates inhibitor repurposing by enabling rapid and efficient identification of novel TKI targets in cells.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...